Chieh-Hsin Wu

Sep 25, 2024 | mdpi.com | Yi-Cheng Tsai |Chih-Hui Chang |Yoon Bin Chong |Chieh-Hsin Wu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Sep 18, 2024 | mdpi.com | Cheng-Yu Tsai |Keng-Liang Kuo |Chieh-Hsin Wu |Tai-Hsin Tsai

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Jun 20, 2024 | mdpi.com | Yi-Cheng Tsai |Chih-Hui Chang |Yoon Bin Chong |Chieh-Hsin Wu

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Apr 24, 2023 | mdpi.com | Tai-Hsin Tsai |Cheng-Yu Tsai |Sin-Hua Moi |Chieh-Hsin Wu

Abstract:2-Cyano-3,12-dioxooleana-1,9(11)-dien-28-oic acid-9,11-dihydro-trifluoroethyl amide (CDDO-dhTFEA) has antioxidant and anti-inflammatory activities; however, whether CDDO-dhTFEA has anticancer effects is unclear. The objective of this research was to investigate the possibility of CDDO-dhTFEA as a potential cancer-fighting treatment in glioblastoma cells.